Why the study?
Does nifedipine GITS reduce blood pressure in patients with mild-to-moderate hypertension?
Does nifedipine GITS reduce blood pressure in patients with mild-to-moderate hypertension?
Nifedipine GITS is an effective and well-tolerated once-daily monotherapy for reducing blood pressure in patients with mild-to-moderate hypertension.
Answers are grounded in this paper and cite their sources.
Nifedipine GITS may lower BP in mild-to-moderate hypertension; leaves open efficacy versus alternatives pending randomized trials.
Nifedipine, in the gastrointestinal therapeutic system (GITS) formulation, a controlled-release formulation for once-a-day administration, was evaluated in the Modern Approach to the Treatment of Hypertension (MATH) trial. In this study conducted at 127 centers, 1155 patients with mild-to-moderate hypertension representative of the spectrum seen in practice were included in the analyses of effectiveness. After a 2 week placebo period, nifedipine GITS therapy was started at 30 mg/day and was titrated to a maximum dose of 180 mg/day over 6 weeks. Response criteria were a sitting diastolic blood pressure < 90 mm Hg and a decrease of ≥10 mm Hg. After titration, patients were observed for 12 weeks during treatment. At the final visit, nifedipine GITS significantly (P < .0001) reduced sitting systolic blood pressure 17 ± 14 mm Hg (mean ± SD), and sitting diastolic blood pressure 14 ± 8 mm Hg. Similar highly significant reductions in standing blood pressure were observed. For all subjects, 76% achieved goal blood pressure response during titration. More than 50% were controlled on doses of 30 to 60 mg/day. At the final visit blood pressure reductions in men and women were similar, except for a significantly greater decrease in sitting systolic pressure for women. A similar proportion of blacks responded compared with whites, and reductions in sitting systolic and diastolic blood pressure were also similar in the 2 groups. Nifedipine GITS had no effect on renal function, serum potassium, or total, HDL, or LDL cholesterol. Uric acid was reduced by 0.5 mg/dL (P < .001). Edema was the most common complaint and was dose-related; < 10% of patients were discontinued from treatment for this symptom. Nifedipine GITS is effective, and well tolerated monotherapy for mild-to-moderate hypertension as usually encountered in medical clinics and practices. Am J Hypertens 1990;3:318S-325S
No takes yet. Share an insight, caveat, or question.
Krakoff et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: